ACE Report Cover
Plasma rich in growth factors effective for high ankle sprain recovery in elite athletes
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
FOOT & ANKLE
Plasma rich in growth factors effective for high ankle sprain recovery in elite athletes .
Verified
This report has been verified by one or more authors of the original publication.

Plasma rich in growth factors (PRGF) as a treatment for high ankle sprain in elite athletes: a randomized control trial

Knee Surg Sports Traumatol Arthrosc. 2015 Nov;23(11):3383-92

15 elite athletes (16 ankles) with grade 3 high ankle sprains, with complete anteroinferior tibiofibular ligament (AITFL) tears, were included in this study. The purpose of the study was to determine how ultrasound-guided platelet-rich in Growth Factor (PRGF) injections effect recovery, return to play, and dynamic stability in this injury. The results displayed that athletes who received PRGF injections had a significantly shorter return to play times and a lower number of patients returning to play with residual pain compared to the control group. Sonographic evaluations displayed no significant differences in the syndesmotic opening between groups up to 6 weeks post-injury. Further trials using larger sample size and a more generalizable patient population are warranted based on the results of this study.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Plasma rich in growth factors effective for high ankle sprain recovery in elite athletes. ACE Report. 2016;5(4):13. Available from: https://myorthoevidence.com/AceReport/Show/plasma-rich-in-growth-factors-effective-for-high-ankle-sprain-recovery-in-elite-athletes

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report